z-logo
open-access-imgOpen Access
Costimulatory signals controlling regulatory T cells
Author(s) -
Joerg Ermann,
C. Garrison Fathman
Publication year - 2003
Publication title -
proceedings of the national academy of sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.011
H-Index - 771
eISSN - 1091-6490
pISSN - 0027-8424
DOI - 10.1073/pnas.0307001100
Subject(s) - longevity , biology , evolutionary biology , history , genealogy , genetics
The concept of specialized suppressor T cells (now commonly called regulatory T cells or Tregs), which was abandoned by most immunologists in the early 1980s (1), was rescued by the description of a marker for their identification and isolation by Sakaguchi et al. (2), who, in 1995, described a CD4+CD25+ subpopulation of T cells that could prevent pathology in a mouse autoimmune disease model. However, the marker CD25, the α-chain of the high-affinity IL-2 receptor, is also induced on conventional T cells after activation. The dilemma arose as to how one could distinguish genuine Tregs from recently activated conventional T cells. Furthermore, the suppressor activity of CD4+CD25+ Tregs in vitro depended on their prior stimulation and could be overcome by strong costimulation (3, 4). What were the signals that controlled the activity of CD4+CD25+ Tregs in vivo that allowed them to inhibit certain immune responses but not others? In a recent issue of PNAS, Tone et al. (5) reported the cloning of the murine ligand for GITR, a tumor necrosis factor receptor superfamily member that had previously been demonstrated to regulate CD4+CD25+ Treg function. Searching for novel Treg markers, two groups had independently found that freshly isolated CD4+CD25+ Treg cells but not conventional CD4+CD25– T cells expressed uniformly high levels of GITR (6, 7). Activation of the CD4+CD25– T cells in vitro rapidly increased GITR surface expression to levels comparable to that on CD4+CD25+ Tregs. GITR thus was no better than CD25 in distinguishing Tregs from activated conventional T cells. However, the addition of anti-GITR antibodies to the coculture of CD4+CD25– and CD4+CD25+ T cells in vitro …

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom